Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies
Int J Clin Oncol. 2023 Mar;28(3):370.
doi: 10.1007/s10147-023-02310-4.
1 Clinical Immunology and Allergy Unit, Department of Clinical and Experimental Medicine, University of Pisa, Via Roma, 67, 56126, Pisa, Italy.
2 Oncology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
3 Sant'Anna School of Advanced Studies, Pisa, Italy.
4 Department of Translational Medicine and New Technologies for Medicine and Surgery, University of Pisa, Pisa, Italy.
5 Hematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
6 Clinical Immunology and Allergy Unit, Department of Clinical and Experimental Medicine, University of Pisa, Via Roma, 67, 56126, Pisa, Italy. paola.migliorini@unipi.it.